VRCA
VRCA
NASDAQ · Pharmaceuticals

Verrica Pharmaceuticals Inc

$4.72
+0.23 (+5.12%)
As of Sep 22, 10:06 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +103.2% upside
Low Target $7.88
Average Target $9.59
High Target $13.36
Current Price $4.72
Current
$4.72
Target
$9.59
$7.88 $9.59 avg $13.36
Scenario Analysis
Bear Case
$7.88
66.9%
Low target
Base Case
$9.59
+103.2%
Avg target
Bull Case
$13.36
+183.1%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$9.82
-51.9% from high
52-Week Low
$3.28
+43.9% from low
Target vs 52W High
$9.59
-2.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%